Other
FAP
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
FAP is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
4
clinical trials
Completed2 · 50%
Terminated2 · 50%
Clinical Trials
Trial Activity
The Effect of Rifapentine on Raltegravir
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT00809718·27 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)